Results 281 to 288 of about 204,987 (288)

Reporting of immune checkpoint inhibitor-associated myocarditis – Authors' reply

Lancet, The, 2018
Joe-Elie Salem, Bénédicte Lebrun-Vignes   +1 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis

Lancet, The, 2018
Joe-Elie Salem, Bénédicte Lebrun-Vignes   +1 more
exaly  

Immunosurveillance in clinical cancer management

Ca-A Cancer Journal for Clinicians
Guido Kroemer, Timothy A Chan, Lorenzo Galluzzi   +2 more
exaly  

Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study

Lancet, The
Toni K Choueiri, Laurence Albiges, Javier Molina-Cerrillo   +2 more
exaly  

Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis

Circulation
Pan Ma, Jing Liu, Juan Qin
exaly  

Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart

Nature Reviews Cancer
Amir Munir, Juan Qin
exaly  

TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinoma

Lancet, The
exaly